Hes, plus the trial was terminated.Other Anti-EGFR Technique Trastuzumab is
Chemexpress Hes, and the trial was terminated.Other Anti-EGFR Tactic Trastuzumab is usually a monoclonal antibody targeting HER2. Within a modest phase II trial, 34 APC patients with tumors Her2/neu overexpression 21/31…